ArticleJournal of clinical microbiology2012

First report of an extensively drug-resistant VIM-2 metallo-β-lactamase-producing Brevundimonas diminuta clinical isolate.

Marisa N Almuzara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.